Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program
Matthews DR, Li Q, Perkovic V, et al.
Diabetologia. 2019;62:926-38
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Matthews DR, Li Q, Perkovic V, et al.
Diabetologia. 2019;62:926-38
Leggi
Rosenson RS, Daviglus ML, Handelsman Y, et al.
Diabetologia. 2019;62:948-58
Leggi
Tamborlane WV, Barrientos-Pérez M, Fainberg U, et al.
N Engl J Med. Pub. online 28 Apr 2019
Leggi
Kivimäki M, Singh-Manoux A, Pentti J, et al.
BMJ. 2019;365:l1495
Leggi
Retnakaran R, Shah BR
Lancet Diabetes Endocrinol. 2019;7(5):378-84
Leggi
Deiss D, Szadkowska A, Gordon D, et al.
Diabetes Technology & Therapeutics. Pub. Online 25 Apr 2019
Leggi
Wei L, Lai EC, Kao-Yang Y, et al.
BMJ. 2019;365:l1204
Leggi
Ramsaran E, Preusse P, Sundaresan D, et al.
Am J Cardiol. Pub. online 23 April 2019
Leggi
Apolzan JW, Venditti EM, Edelstein SL, et al.
Ann Intern Med. Pub. online 23 April 2019
Leggi
Ludvigsson JF, Neovius M, Söderling J, et al.
Ann Intern Med. Pub. online 23 April 2019
Leggi